Price:
Rs. 12,400.00
Sample Type: BLOOD
Fasting Not Required
Notes: L0141
Frequently Asked Questions (FAQ's):
What does the Leukemia Mutation Panel AML test include?
It identifies key genetic mutations seen in Acute Myeloid Leukemia to support diagnosis and treatment planning.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare utilizes advanced molecular techniques, including PCR and sequencing-based analysis, ensuring high sensitivity and accuracy.
Who should take this test?
Patients diagnosed with or suspected of having AML, or those undergoing treatment monitoring or relapse evaluation.
What sample is required for this test?
A blood sample collected in an EDTA tube.
How long does Metropolis Healthcare take to provide results?
Results are typically available within 10–14 working days depending on complexity.
How do the results help in treatment decisions?
They assist in risk stratification, response prediction to targeted therapies, and bone marrow transplant suitability.
Is this test useful for monitoring disease progression?
Yes, it is valuable during follow-up to detect minimal residual disease or relapse.
Does Metropolis Healthcare offer expert clinical consultation?
Yes, genetic and hematology specialists at Metropolis Healthcare help interpret results for optimized patient care